HirudinFISCHER, Karl-Georg; SUTOR, Anton H.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 5, issn 0094-6176Serial Issue

Thrombopénies induites par l'héparine (TIH) de type II: apport d'une nouvelle hirudine recombinante = Type II heparin-induced thrombocytopeniaLa Presse médicale (1983). 1998, Vol 27, issn 0755-4982, 32 p., SUP2Conference Proceedings

Actualités en thérapeutique antithrombotique : de la sangsue à l'hirudine recombinante = news in antithrombotic therapy: from leech to recombinant hirudinBIRON-ANDREANI, C.Angéiologie (Paris). 1999, Vol 51, Num 2, pp 26-30, issn 0003-3049Article

Measurement of hematological, clinical chemistry, and infection parameters from hirudinized blood collected in universal blood sampling tubesMENSSEN, Hans D; BRANDT, Natascha; LEBEN, Rainer et al.Seminars in thrombosis and hemostasis. 2001, Vol 27, Num 4, pp 349-356, issn 0094-6176Article

Development of a responsive methanol sensor and its application in Pichia pastoris fermentationZHOU, Xiang-Shan; JIAN LU; FAN, Wei-Min et al.Biotechnology letters. 2002, Vol 24, Num 8, pp 643-646, issn 0141-5492Article

Comparison of three methods for measuring PEG-hirudin in bloodHOFFMANN, J. J. M. L; JANSSEN, W. C. M.Blood coagulation & fibrinolysis. 2001, Vol 12, Num 7, pp 577-581, issn 0957-5235Conference Paper

Potent antithrombin activity and delayed clearance from the circulation characterize recombinant hirudin genetically fused to albuminSYED, S; SCHUYLER, P. D; KULCZYCKY, M et al.Blood. 1997, Vol 89, Num 9, pp 3243-3252, issn 0006-4971Article

Covalent immobilization of hirudin improves the haemocompatibility of polylactide-polyglycolide in vitroSEIFERT, B; ROMANIUK, P; GROTH, T et al.Biomaterials. 1997, Vol 18, Num 22, pp 1495-1502, issn 0142-9612Article

Development of direct thrombin inhibitors in comparison with glycosaminoglycansMARKWARDT, Fritz.Seminars in thrombosis and hemostasis. 2001, Vol 27, Num 5, pp 523-530, issn 0094-6176Article

Evaluation of a novel hirudin-coated polyester graft to physiologic flow conditions : Hirudin bioavailability and thrombin uptake. DiscussionBERCELI, S. A; PHANEUF, M. D; LOGERFO, F. W et al.Journal of vascular surgery. 1998, Vol 27, Num 6, pp 1117-1127, issn 0741-5214Conference Paper

Hirudine : échec relatif d'une molécule très prometteuse = Hirudin : The relative failure of a very promising moleculeAIACH, M.Archives des maladies du coeur et des vaisseaux. 1996, Vol 89, Num 11, pp 1485-1490, issn 0003-9683, SUPArticle

Les inhibiteurs directs de la thrombine, l'hirudine, la bivalirudine, l'argatroban, et le dabigatran etexilate = Direct inhibitors of thrombin, hirudin, bivalirudin, and dabigatran etexilateMEDDAHI, S; SAMAMA, M. M.Journal des maladies vasculaires. 2011, Vol 36, Num 1, pp 24-32, issn 0398-0499, 9 p.Article

Comparison of monitoring methods for lepirudin: Impact of warfarin and lupus anticoagulantSALMELA, Birgitta; JOUTSI-KORHONEN, Lotta; SAARELA, Ellen et al.Thrombosis research. 2010, Vol 125, Num 6, pp 538-544, issn 0049-3848, 7 p.Article

Rationale and Design of the PREVENT-HIT Study: A Randomized, Open-Label Pilot Study to Compare Desirudin and Argatroban in Patients With Suspected Heparin-Induced Thrombocytopenia With or Without ThrombosisFRAME, James N; RICE, Lawrence; BARTHOLOMEW, John R et al.Clinical therapeutics. 2010, Vol 32, Num 4, pp 626-636, issn 0149-2918, 11 p.Article

Controlled delivery of recombinant hirudin based on thermo-sensitive Pluronic® F127 hydrogel for subcutaneous administration : In vitro and in vivo characterizationYU LIU; LU, Wan-Liang; WANG, Jian-Cheng et al.Journal of controlled release. 2007, Vol 117, Num 3, pp 387-395, issn 0168-3659, 9 p.Article

Inhibition of thrombin generation in recalcified plasmaSTIEF, Thomas W.Blood coagulation & fibrinolysis. 2007, Vol 18, Num 8, pp 751-760, issn 0957-5235, 10 p.Article

Determination of antithrombin-dependent factor xa inhibitors by prothrombin-induced clotting timeHARENBERG, Job; GIESE, Christina; HAGEDORN, Antje et al.Seminars in thrombosis and hemostasis. 2007, Vol 33, Num 5, pp 503-507, issn 0094-6176, 5 p.Conference Paper

Off-pump coronary artery bypass grafting in a heparin-induced thrombocytopenia type II patient using hirudinCARR, Cornélia S; RAYNER, Alan; PONTE, José et al.The Annals of thoracic surgery. 2005, Vol 79, Num 2, pp 696-698, issn 0003-4975, 3 p.Article

Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y₁₂ and P2Y₁ antagonists but not aspirinSTOREY, Robert F; MAY, Jane A; HEPTINSTALL, Stan et al.Thrombosis research. 2005, Vol 115, Num 4, pp 301-307, issn 0049-3848, 7 p.Article

Inhibition of intravascular thrombosis in murine endotoxemia by targeted expression of hirudin and tissue factor pathway inhibitor analogs to activated endotheliumDAXIN CHEN; GIANNOPOULOS, Konstantinos; SHIELS, Paul G et al.Blood. 2004, Vol 104, Num 5, pp 1344-1349, issn 0006-4971, 6 p.Article

Direct thrombin inhibitors in acute coronary syndromes: Present and futureWEITZ, Jeffrey I; BULLER, Harry R.Circulation (New York, N.Y.). 2002, Vol 105, Num 8, pp 1004-1011, issn 0009-7322Article

Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' dataLancet (British edition). 2002, Vol 359, Num 9303, pp 294-302, issn 0140-6736Article

Management of patients with acute coronary syndromes: What is the clinical role of direct thrombin inhibitors?EIKELBOOM, John W; FRENCH, John.Drugs (Basel). 2002, Vol 62, Num 13, pp 1839-1852, issn 0012-6667, 14 p.Article

Vers des anticoagulants plus actifs et plus sûrs = To more active and safe anticoagulantsELSCHEB, Anne-Marie; LOCHOUARN, Martine.Concours médical (Paris). 2002, Vol 124, Num 37, pp 2415-2417, issn 0010-5309, 3 p.Article

Hirudin as alternative anticoagulant: A historical reviewMARKWARDT, Fritz.Seminars in thrombosis and hemostasis. 2002, Vol 28, Num 5, pp 405-413, issn 0094-6176, 9 p.Article